| __timestamp | Gilead Sciences, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 24890000000 | 759285000 |
| Thursday, January 1, 2015 | 32639000000 | 862944000 |
| Friday, January 1, 2016 | 30390000000 | 950751000 |
| Sunday, January 1, 2017 | 26107000000 | 879387000 |
| Monday, January 1, 2018 | 22127000000 | 661913000 |
| Tuesday, January 1, 2019 | 22449000000 | 669893000 |
| Wednesday, January 1, 2020 | 24689000000 | 644769000 |
| Friday, January 1, 2021 | 27305000000 | 548970000 |
| Saturday, January 1, 2022 | 27281000000 | 561347000 |
| Sunday, January 1, 2023 | 27116000000 | 572952000 |
| Monday, January 1, 2024 | 28754000000 | 629182000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, revenue is a key indicator of success. From 2014 to 2023, Gilead Sciences, Inc. consistently outperformed Taro Pharmaceutical Industries Ltd. in annual revenue. Gilead's revenue peaked in 2015 at approximately $32.6 billion, a staggering 3,700% higher than Taro's revenue in the same year. Despite fluctuations, Gilead maintained a strong lead, with its lowest revenue in 2018 still being over 3,200% higher than Taro's highest revenue in 2016. Taro, on the other hand, experienced a gradual decline, with its revenue dropping by about 24% from 2016 to 2023. The data for 2024 is incomplete, but the trend suggests Gilead's dominance in revenue generation remains unchallenged. This analysis highlights the significant revenue gap between these two pharmaceutical giants over the past decade.
Revenue Showdown: AstraZeneca PLC vs Gilead Sciences, Inc.
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Gilead Sciences, Inc. and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Gilead Sciences, Inc. vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Gilead Sciences, Inc. or Geron Corporation
Revenue Insights: Gilead Sciences, Inc. and Dynavax Technologies Corporation Performance Compared
Revenue Showdown: Gilead Sciences, Inc. vs Galapagos NV
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
ADMA Biologics, Inc. vs Taro Pharmaceutical Industries Ltd.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Geron Corporation or Taro Pharmaceutical Industries Ltd.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs Galapagos NV